P&G saw three new federal suits that center on allegedly deceptive environmental claims on its Charmin and Puffs paper ...

Learn about lowering drug prices in the U.S. with new policies aimed at achieving the lowest rates among high-income countries.

Regeneron Pharmaceuticals is purchasing genetics and biotechnology company 23andMe and has vowed to protect customer data while continuing genome testing services. Regeneron announced the purchase ...

Bankrupt DNA testing company 23andMe was purchased Monday by biotechnology company Regeneron for $256 million. Both companies insisted the sensitive genetic data provided to 23andMe by 15 million ...

Regeneron Pharmaceuticals, which has a plant in Rensselaer County, is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11. Biotechnology company ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said ...

Genetic data was on the auction block, and a U.S. biotech company ponied up the cash. New York-based Regeneron Pharmaceuticals announced on Monday that it has purchased DNA testing company 23andMe ...

President Trump signs an executive order to reduce prescription drug costs in the U.S. Discover the changes and potential impacts.

A week after one New Haven-based biotechnology company announced a mass layoff, another has announced plans to cut 40% of its workforce. RallyBio, based at 234 Church St., in New Haven ...

Unity Biotechnology, a Bay Area company that once won high-profile backers and a $700 million valuation for its research into aging, is now laying off every one of its remaining employees.